Overview
Po-jung Su practices in Taoyuan, Taiwan. Su is highly rated in 1 condition, according to our data. Their top areas of expertise are Leukocytosis, Urothelial Cancer, Bladder Cancer, and Esophageal Cancer.
Their clinical research consists of co-authoring 46 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- LeukocytosisSu isAdvanced. Learn about Leukocytosis.
- Experienced
- Bladder CancerSu isExperienced. Learn about Bladder Cancer.
- End-Stage Renal Disease (ESRD)
- Erythema MultiformeSu isExperienced. Learn about Erythema Multiforme.
- Esophageal CancerSu isExperienced. Learn about Esophageal Cancer.
- Prostate CancerSu isExperienced. Learn about Prostate Cancer.
- Stevens-Johnson Syndrome